Goldman Sachs Call 25 FRE 21.03.2.../ DE000GG5LKC6 /
1/23/2025 10:24:36 AM | Chg.+0.02 | Bid10:00:26 PM | Ask10:00:26 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.16EUR | +1.75% | - Bid Size: - |
- Ask Size: - |
FRESENIUS SE+CO.KGAA... | 25.00 - | 3/21/2025 | Call |
GlobeNewswire
4/24/2024
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
4/23/2024
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
2/23/2024
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
9/4/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
8/31/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil